The Euro Heart Failure Survey of the EUROHEART survey programme. A survey on the quality of care among patients with heart failure in Europe. The Study Group on Diagnosis of the Working Group on Heart Failure of the European Society of Cardiology. The Medicines Evaluation Group Centre for Health Economics University of York.

Baseline characteristics and hospital mortality in the Acute Heart Failure Database (AHEAD) Main registry. Crit Care (2011) 0.97

Prevalence and incidence of arrhythmias and sudden death in heart failure. Heart Fail Rev (2002) 0.96

Clinical and economic aspects of the use of nebivolol in the treatment of elderly patients with heart failure. Clin Interv Aging (2010) 0.81

Coronary sinus dilatation is associated with left ventricular systolic dysfunction and poor functional status in subjects with chronic heart failure. Int J Cardiovasc Imaging (2010) 0.80

Northern Territory Heart Failure Initiative-Clinical Audit (NTHFI-CA)-a prospective database on the quality of care and outcomes for acute decompensated heart failure admission in the Northern Territory: study design and rationale. BMJ Open (2014) 0.80

Telemonitoring for heart failure: the only feasible option for good universal care? Eur J Heart Fail (2009) 0.80

Utilisation of medications recommended for chronic heart failure and the relationship with annual hospitalisation duration in patients over 75 years of age. A pharmacoepidemiological study. Eur J Clin Pharmacol (2005) 0.79

Rationale, design and baseline results of the Treatment Optimisation in Primary care of Heart failure in the Utrecht region (TOPHU) study: a cluster randomised controlled trial. BMC Fam Pract (2015) 0.78

Renal dysfunction in acute heart failure. Korean Circ J (2011) 0.78

Contemporary management of heart failure in clinical practice. Heart (2002) 0.77

Mineralocorticoid receptor antagonist use in hospitalized patients with heart failure, reduced ejection fraction, and diabetes mellitus (from the EVEREST Trial). Am J Cardiol (2014) 0.77

Quality markers in cardiology: measures of outcomes and clinical practice-a perspective of the Spanish Society of Cardiology and of Thoracic and Cardiovascular Surgery. Eur Heart J (2015) 0.76

Relation between severity of left ventricular systolic dysfunction and repolarisation abnormalities on the surface ECG: a report from the Euro heart failure survey. Heart (2006) 0.76

Chronic obstructive pulmonary disease (COPD) during the two last years of life--a retrospective study of decedents. PLoS One (2013) 0.76

Outcome of heart failure with preserved ejection fraction: a multicentre spanish registry. Curr Cardiol Rev (2009) 0.75

Influence of myocardial ischemia on outcomes in patients with systolic versus non-systolic heart failure. Am J Cardiovasc Dis (2011) 0.75

Impact of formal continuing medical education: do conferences, workshops, rounds, and other traditional continuing education activities change physician behavior or health care outcomes? JAMA (1999) 13.39

The use of statins: a case of misleading priorities? BMJ (1997) 13.35

Rising emergency admissions. BMJ (1995) 7.80

Effect of nesiritide in patients with acute decompensated heart failure. N Engl J Med (2011) 7.62

Educational outreach visits: effects on professional practice and health care outcomes. Cochrane Database Syst Rev (2007) 7.25

Continuing education meetings and workshops: effects on professional practice and health care outcomes. Cochrane Database Syst Rev (2001) 7.24

Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability. BMJ (1993) 7.14

Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis. BMJ (2000) 6.67

Developing and implementing clinical practice guidelines. Qual Health Care (1995) 6.52

WITHDRAWN: Treatment discontinuation with selective serotonin reuptake inhibitors (SSRIs) versus tricyclic antidepressants (TCAs). Cochrane Database Syst Rev (2007) 6.02

Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J (2001) 5.77

beta Blockade after myocardial infarction: systematic review and meta regression analysis. BMJ (1999) 5.66

Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group. JAMA (2000) 5.49

Effect on mortality of metoprolol in acute myocardial infarction. A double-blind randomised trial. Lancet (1981) 4.75

Large computer databases in general practice. BMJ (1991) 4.58

North of England evidence based guidelines development project: guideline for the primary care management of dementia. BMJ (1998) 4.39

Randomised controlled trial of clinical medication review by a pharmacist of elderly patients receiving repeat prescriptions in general practice. BMJ (2001) 4.21

The EuroHeart Failure survey programme-- a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. Eur Heart J (2003) 4.09

Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure. J Am Coll Cardiol (2001) 4.07

Contrast media-enhanced magnetic resonance imaging visualizes myocardial changes in the course of viral myocarditis. Circulation (1998) 3.99

Clinical applications of B-type natriuretic peptide (BNP) testing. Eur Heart J (2003) 3.78

Not playing with a full DEC: why development and evaluation committee methods for appraising new drugs may be inadequate. BMJ (1999) 3.60

TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination. Nat Neurosci (2001) 3.50

Promoting cost effective prescribing. BMJ (1995) 3.46

Deprivation payments revisited (again) BMJ (1996) 3.45

Randomised study of effect of ibopamine on survival in patients with advanced severe heart failure. Second Prospective Randomised Study of Ibopamine on Mortality and Efficacy (PRIME II) Investigators. Lancet (1997) 3.30

Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group. Lancet (1993) 3.20

North of England evidence based guidelines development project: methods of developing guidelines for efficient drug use in primary care. BMJ (1998) 3.14

Educational outreach visits: effects on professional practice and health care outcomes. Cochrane Database Syst Rev (2000) 3.04

Social deprivation and prognostic benefits of cardiac surgery: observational study of 44 902 patients from five hospitals over 10 years. BMJ (2009) 2.95

Systematic review and economic evaluation of Helicobacter pylori eradication treatment for non-ulcer dyspepsia. Dyspepsia Review Group. BMJ (2000) 2.92

The EuroHeart Failure Survey programme--a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment. Eur Heart J (2003) 2.78

Prevention of one-year vein-graft occlusion after aortocoronary-bypass surgery: a comparison of low-dose aspirin, low-dose aspirin plus dipyridamole, and oral anticoagulants. The CABADAS Research Group of the Interuniversity Cardiology Institute of The Netherlands. Lancet (1993) 2.77

Differences between patients with a preserved and a depressed left ventricular function: a report from the EuroHeart Failure Survey. Eur Heart J (2004) 2.73

North of England evidence based development project: guideline for angiotensin converting enzyme inhibitors in primary care management of adults with symptomatic heart failure. BMJ (1998) 2.72

The problem of chronic refractory angina; report from the ESC Joint Study Group on the Treatment of Refractory Angina. Eur Heart J (2002) 2.68

Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): an international survey. Lancet (2002) 2.61

Something rotten in the state of clinical and economic evaluations? Health Econ (1994) 2.50

Aggression and the general practitioner. BMJ (1989) 2.50

Deprivation payments. BMJ (1993) 2.46

Near patient testing in primary care. BMJ (1996) 2.42

Local opinion leaders: effects on professional practice and health care outcomes. Cochrane Database Syst Rev (2000) 2.33

One-year mortality among unselected outpatients with heart failure. Eur Heart J (2002) 2.30

Cardiopulmonary auscultation: duo for strings--Opus 99. Arch Intern Med (1999) 2.26

Longterm follow-up of patients with pulmonary thromboembolism. Late prognosis and evolution of hemodynamic and respiratory data. Chest (1982) 2.23

Clinical effects of early angiotensin-converting enzyme inhibitor treatment for acute myocardial infarction are similar in the presence and absence of aspirin: systematic overview of individual data from 96,712 randomized patients. Angiotensin-converting Enzyme Inhibitor Myocardial Infarction Collaborative Group. J Am Coll Cardiol (2000) 2.22

EUR-ASSESS Project Subgroup Report on Dissemination and Impact. Int J Technol Assess Health Care (1997) 2.18

A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: The Flolan International Randomized Survival Trial (FIRST). Am Heart J (1997) 2.16

North of England evidence based guideline development project: guideline on the use of aspirin as secondary prophylaxis for vascular disease in primary care. North of England Aspirin Guideline Development Group. BMJ (1998) 2.15

p53 regulates mitochondrial membrane potential through reactive oxygen species and induces cytochrome c-independent apoptosis blocked by Bcl-2. EMBO J (1999) 2.14

North of England evidence-based guideline development project: summary version of guidelines for the choice of antidepressants for depression in primary care. North of England Anti-depressant Guideline Development Group. Fam Pract (1999) 2.09

Diltiazem in acute myocardial infarction treated with thrombolytic agents: a randomised placebo-controlled trial. Incomplete Infarction Trial of European Research Collaborators Evaluating Prognosis post-Thrombolysis (INTERCEPT) Lancet (2000) 2.08

When is it cost-effective to change the behavior of health professionals? JAMA (2001) 2.08

Carcinogenic activity of bracken. Nature (1965) 2.03

A national survey of heart failure in French hospitals. The Myocardiopathy and Heart Failure Working Group of the French Society of Cardiology, the National College of General Hospital Cardiologists and the French Geriatrics Society. Eur Heart J (2000) 2.03

How to develop cost-conscious guidelines. Health Technol Assess (2001) 2.03

Serum level monitoring of antibacterial drugs. A review. Clin Pharmacokinet (1985) 2.01

Prognostic usefulness of the tricuspid annular plane systolic excursion in patients with congestive heart failure secondary to idiopathic or ischemic dilated cardiomyopathy. Am J Cardiol (2000) 1.86